BDBM463549 2-(4-Fluorophenyl)-3-(3-oxopiperazin-1-yl)quinoxaline-6-carboxylic acid::US10781185, Example 103::US11459307, Example 103

SMILES OC(=O)c1ccc2nc(-c3ccc(F)cc3)c(nc2c1)N1CCNC(=O)C1

InChI Key InChIKey=JSWQYEUTVFKVSA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 463549   

TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM463549(2-(4-Fluorophenyl)-3-(3-oxopiperazin-1-yl)quinoxal...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM463549(2-(4-Fluorophenyl)-3-(3-oxopiperazin-1-yl)quinoxal...)
Affinity DataIC50: <1.00E+3nMAssay Description:Compound screening was done via the following method. 10 mM stock solution of test compound in DMSO was prepared by dissolving test compound in DMSO ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent